baber/WOPTO huggingface dataset:
Patent NZ-591594-A (NZ)
Title: Transcription factor decoys
Inventor: MCARTHUR MICHAEL
IPC: C12N1/21
Filed: 2009-10-02
Abstract: 591594 TRANSCRIPTION FACTOR DECOYS Provided is A decoy polynucleotide comprising a binding site for a target transcription factor, wherein the binding site is not operably linked to a gene, and wherein the transcription factor comprises a regulator of expression of a gene or genes encoding a cellular stress response, and wherein the target transcription factor is selected from: WhiB7; FadR; YycG/YycF; Sigma 54 (or SigA); Fur; TcdR; Vfr; NtrC; ArsR; TcaA; AgrA; WalR; sigB; Ksig; or fhu. The compositions can be used to treat bacterial infections.
Patent NZ-602583-A (NZ)
Title: Methods of using diacerein as an adjunctive therapy for diabetes
Inventor: KU MANNCHING SHERRY
IPC: C07C50/34
Filed: 2011-04-07
Abstract: Disclosed is the use of therapeutically effective amount (preferably from 25 to 200 mg per day) of diacerein or a pharmaceutically acceptable salt thereof, monoacetylrhein or rhein, for preparing a medicament for treating type II diabetes mellitus in a subject with type II diabetes who has an inadequate response to an antidiabetic agent and whose hemoglobin A1c value is above 7%. The disclosure also relates to the use if a combination of (a) a therapeutically effective amount of diacerein, or a pharmaceutically acceptable salt thereof, monoacetylrhein or rhein, and (b) an antidiabetic agent selected from the group consisting of sulfonylurea, a biguanide, an alpha-glucosidase inhibitor, a thiazolidinedione, a peroxisome proliferator-activated receptor agonist, a dipeptidyl peptidase-4 inhibitor, a nonsulfonylurea insulin secretagogue, a glucagon-like petide-1 analog and insulin, for preparing a medicament for improving glycemic control in a subject with type II diabetes mellitus receiving at least one antidiabetic agent and whose hemoglobin A1c value is above 7%.
Patent NZ-606549-A (NZ)
Title: Inactivated varicella zoster virus vaccines, methods of production, and uses thereof
Inventor: KRAH DAVID L
IPC: A61K39/00
Filed: 2011-08-04
Abstract: Discloses an inactivated varicella zoster virus (VZV), and compositions and vaccines comprising said inactivated VZV, wherein the infectivity of the VZV is undetectable and wherein the inactivated VZV induces an immune response against VZV when administered to a patient. In embodiments of the compositions described herein, the VZV is inactivated with gamma radiation. Also disclosed is a method of preparing an inactivated VZV vaccine, the method comprising gamma irradiating a sample comprising a VZV using from about 5 kGy to about 50 kGy of gamma radiation. Also disclosed is a method of treatment of or immunization against HZ or other disease associated with the reactivation of VZV, the method comprising administering to a subject a vaccine or pharmaceutical composition comprising a therapeutically effective amount of an inactivated VZV and a pharmaceutically acceptable carrier, wherein the VZV is inactivated by gamma irradiation.
Patent NZ-607069-A (NZ)
Title: Modified relaxin polypeptides and their uses
Inventor: KRAYNOV VADIM
IPC: C07K14/64
Filed: 2011-08-17
Abstract: Disclosed is a modified relaxin polypeptide comprising at least one non-naturally encoded amino acid, wherein: (a) the modified relaxin polypeptide comprises a relaxin A chain polypeptide and a relaxin B chain polypeptide, wherein said relaxin A chain polypeptide has a sequence at least 85% identical to SEQ ID NO: 4, and said relaxin B chain polypeptide has a sequence at least 85% identical to SEQ ID NO: 5 or SEQ ID NO: 6; and (b) the non-naturally encoded amino acid has the structure as defined herein wherein said non-naturally encoded amino acid is linked to a linker, polymer, or biologically active molecule.
Patent NZ-609625-A (NZ)
Title: Automated wood species identification
Inventor: BENOIT GHISLAIN
IPC: G01N33/46
Filed: 2011-09-23
Abstract: Embodiments provide methods, apparatuses, and systems for identification of wood species based on one or more pitch characteristics. A work piece (220) may be exposed to a beam of radiation from a radiation source. The beam of radiation may cause pitch (sap) on or within the work piece to emit visible light. The emitted light may be imaged and used to determine pitch content, pitch location, a pitch deposition pattern, pitch emission wavelength, and/or other characteristics of the work piece. One or more of these characteristics may be used to identify a tree species or group of tree species from which the work piece was cut or manufactured.
Patent NZ-612057-A (NZ)
Title: Control method for determining cure status of glass fiber products
Inventor: HAWKINS CHRISTOPHER M
IPC: B29C48/92
Filed: 2011-12-07
Abstract: A method of determining the cure status of a mineral fiber product such as glass fibre insulation is disclosed. The method involves visually inspecting the mineral fiber product to identify representative samples of undercured or overcured regions. The samples are then quantitatively assessed to determine the cure status of the binder which can then be used to adjust or modify the production process where the quantitatively assessment is based on a measure of pH.
Patent NZ-618793-A (NZ)
Title: Composition for treating diabetes comprising long-acting insulin conjugate and long-acting insulinotropic peptide conjugate
Inventor: WOO YOUNG EUN
IPC: C07K16/00
Filed: 2012-06-01
Abstract: The disclosure relates to a composition comprising a long-acting insulin conjugate and a long-acting insulinotropic peptide conjugate wherein each of the long-acting insulin conjugate and the long-acting insulinotropic peptide conjugate is prepared by linking insulin or insulinotropic peptide with an immunoglobulin Fc region via a non-peptidyl linker selected from the group consisting of polyethylene glycol, polypropylene glycol, ethylene glycol-propylene glycol copolymer, polyoxyethylated polyol, polyvinyl alcohol, polysaccharide, dextran, polyvinyl ethyl ether, a biodegradable polymer, a lipid polymer, chitin, hyaluronic acid, and a combination thereof. The immunoglobulin Fc region may be an Fc region derived from IgG, IgA, IgD, IgE, or IgM. The disclosure also relates to the use of this composition for the prevention or treatment of diabetes.
Patent NZ-620923-A (NZ)
Title: Furniture seating
Inventor: WEBSTER JAMES ALEXANDER EDEN
IPC: A47C27/08
Filed: 2010-02-05
Abstract: A furniture seat assembly (10) is disclosed. Bean-bag assemblies are typically formed from a loose and fully enclosed bag or liner that is partially filled with a fill material, such as polystyrene pellets, beads, beans or similar. As a person sits on the bean-bag, the fill material within the liner moves fluidly and redistributes within the internal volume of the liner so as to surround and support the body of the person sitting. The bean-bags described above tend to be light-weight and cheap relative to wooden furniture but tend to take the form of an amorphous blob. While the light-weight aspect is advantageous in many applications, the amorphous look can often be considered as having an untidy appearance and may not be considered suitable for use in certain settings, such as in the hospitality industry, in restaurants and bars, or in any other domestic or commercial environment in which the user requires a more defined furniture seating shape for aesthetic reasons. In view of the above the disclosed furniture assembly has a more rigid and structured shape to the bean-bags, but maintain their light-weight and cost benefits relative to solid wooden furniture. The assembly has a fillable liner (12) comprising two or more adjoined chambers (14a-14e), connected by ports (30a-30d), that collectively define a predetermined exterior seat shape when filled. A liner opening (32) is provided to enable filling of the chambers. The chambers are substantially filled with fill material (18) to form the liner into the exterior seat shape ready for use.
Patent NZ-630914-A (NZ)
Title: Methods of treating diabetes and/or promoting survival of pancreatic islets after transplantation
Inventor: MONTELEONE GIOVANNI
IPC: C12N15/113
Filed: 2013-04-18
Abstract: Disclosed is the use of an effective amount of an antisense oligonucleotide against SMAD7 comprising a sequence selected from the group consisting of SEQ ID No: 3, SEQ ID No: 6, SEQ ID No: 8, SEQ ID No: 10 and SEQ ID No: 12 in the manufacture of a medicament for treating and/or preventing diabetes, wherein the sequences are as disclosed in the complete specification.
Patent NZ-706838-A (NZ)
Title: Use of p3 of bacteriophage fusion proteins as amyloid binding agents
Inventor: KRISHNAN RAJARAMAN
IPC: G01N33/00
Filed: 2013-10-01
Abstract: The invention relates to agents and to pharmaceutical compositions for reducing the formation of amyloid and/or for promoting the disaggregation of amyloid proteins. The compositions may also be used to detect amyloid.
Patent NZ-720016-A (NZ)
Title: Modular building
Inventor: UNGER SUSAN
IPC: E04H1/12
Filed: 2013-07-11
Abstract: A modular building unit 16 for construction of a building 10 is disclosed. The modular building unit 16A comprises a structural frame 40 suitable for interconnection to another modular building unit 16B, 16C in construction of the building and a stud frame panel 80 inwardly disposed from an external-most parallel face of an adjacent vertical post of the structural frame 40 and fixed to the structural frame 40. The modular building unit is suitable for handling as a shipping container for transport. The stud frame panel 80 comprises a frame 160 and a plurality of studs which configure the stud frame panel 80 to be structurally load bearing. The structural frame 40 and the stud frame panel 80 are connected so as to be load bearing in combination.
Patent NZ-729291-A (NZ)
Title: Kit for radiolabelling with 68ga comprising a metal inhibitor
Inventor: WOUTERS LUDOVIC
IPC: A61K103/00
Filed: 2015-07-28
Abstract: The present invention relates to a kit for radiolabelling a targeting agent with gallium-68. The present invention also relates to the use of said kit for radiolabelling a targeting agent, a method for radiolabelling a targeting agent with gallium-68 using said kit, said kit and a method of preparation.
Patent NZ-730337-A (NZ)
Title: Method of manufacturing enteric seamless soft capsule
Inventor: MASUDA KOJI
IPC: A61K47/42
Filed: 2015-10-06
Abstract: The present invention addresses the problem of providing a method of producing seamless soft capsules that have an enteric coating and exhibit superior production characteristics.　In this method, enteric-coated seamless soft capsules are produced by means of steps (a) and (b), which are: (a) a step for preparing an enteric capsule coating solution which has a viscosity of 60-127 mPa·s at 50°C and contains gelatin and a low methoxyl pectin having a degree of esterification of 0-40% and a degree of amidation of 0-25%; and (b) a step for encapsulating capsule contents by means of a falling-drop technique using the prepared enteric capsule coating solution. It is preferable for the gelatin to have a jelly strength of 180-330 Bloom, for the viscosity of a 2 mass percent solution of the low methoxyl pectin to be 8-15 mPa·s at a temperature of 35°C, and for the enteric capsule coating solution to contain 10-20 parts by mass of the low methoxyl pectin per 100 parts by mass of the gelatin.
Patent NZ-752502-A (NZ)
Title: A Method For Controlling Glycosylation Of Recombinant Glycoprotein
Inventor: KIM KYU YONG
IPC: C07K14/62
Filed: 2015-12-30
Abstract: The controlling the glycoprotein structures is very important in the field of development of recombinant glycoprotein products for medicines and development of mass production technology. The present invention relates to a method for controlling a glycosylation pattern of a recombinant glycoprotein, comprising culturing a cell comprising polynucleotide encoding a recombinant glycoprotein in a culture medium comprising insulin. The method for controlling the glycosylation of the recombinant glycoprotein according to the present invention can control an activity, folding, secretion, stability, a half-life in plasma, and an immune response of the recombinant glycoprotein.
Patent NZ-757861-A (NZ)
Title: Catheter tubing with tailored modulus response
Inventor: LIM LISA
IPC: A61M25/00
Filed: 2018-04-05
Abstract: Catheter tubing comprises: an elongate body comprising a base thermoplastic polyurethane; and a compounded thermoplastic polyurethane co-extruded with the base thermoplastic polyurethane to provide a section of catheter tubing discrete from the elongate body, the compounded thermoplastic polyurethane comprising a thermoplastic polyurethane and a radiopaque material, wherein the catheter tubing comprises a first elastic modulus under first conditions prior to entry into a patient; and wherein when exposed to second conditions comprising two or more in vivostimuli for a duration of time the catheter tubing comprises a second elastic modulus that is not more than fifty percent of the first modulus. The first elastic modulus is at least 1300 MPa.
Patent PT-100592-A (PT)
Title: Improvements in variable correcting and/or tuning capacitors.
Inventor: CUESTA JUAN MANUEL GARCIA
IPC: H01G5/00
Filed: 1992-06-12
Abstract: The invention refers to improvements in variable correcting and/or tuning capacitors. The improved capacitor consists of a cylindrical body 1 made of tetrafluoroethylene into which a bolt 5 is screwed that expands the material of the cylindrical body outwards, to be housed in radial orifices 4, offset 90 degree from one another, provided for this purpose in the corresponding metal sleeve 3 mounted in this cylindrical body 1, this forming the actual dielectric insulator of the capacitor. The device in question is fastened into the frame 2 by means of a knurled metal ring 7, with appropriate dimensions so that, when the bolt 5 is screwed in, as it passes through it a displacement of material takes place from the latter to the interior, ensuring the electrical contact between the two elements. <IMAGE>
Patent PT-101964-A (PT)
Inventor: RODRIGUEZ-CAVAZOS ENRIQUE
IPC: H04N5/44
Filed: 1997-02-05
Abstract: A convergence control system for multiple vertical modes or formats, having respective rasters with different vertical heights, comprises a selector (4) for initiating operation in one of the available vertical modes, and a circuit (40) for generating convergence correction signals responsive to the selector. The correction signals are generated from known convergence correction values and by interpolation of the known values. The convergence correction values may be stored and sequentially processed by digital circuits and the interpolation may be undertaken by analog circuits. The circuit for generating convergence correction signals may comprise a digital data store (46) for different sets of convergence correction values, for generating selectable sets of correction signals for different vertical modes or formats, for example normal and overscanned modes. The sets of convergence correction values define different sets of grid lines and rows of horizontal scan lines. Adjacent ones of the grid lines are spaced from one another at different intervals for different vertical formats. The intervals between adjacent horizontal grid lines are greater for vertical formats having rasters with greater vertical heights. An interpolating circuit (40) for processing the known convergence correction values is responsive to the horizontal deflection circuit. The interpolating intervals can be adjusted to correspond to the horizontal scanning rate. The number of interpolating intervals is matched to the number of horizontal scan lines in each row. <IMAGE>
Patent PT-106263-A (PT)
Title: Colector solar térmico transparente de baixo custo acoplável à superfície frontal de um módulo fotovoltaico padrão
Inventor: LEANDRO RICARDO JORGE
IPC: F24S10/40
Filed: 2012-04-19
Abstract: A PRESENTE INVENÇÃO REFERE-SE A UM COLECTOR SOLAR TÉRMICO TRANSPARENTE PARA UM MÓDULO FOTOVOLTAICO PADRÃO QUE COMPREENDE UM SISTEMA DE ABSORÇÃO DA RADIAÇÃO SOLAR COM UMA PLACA ABSORSORA TRANSPARENTE (1), AFASTADA DO MÓDULO FOTOVOLTAICO, LIGADA COM FIXAÇÃO, POR INTERMÉDIO DE JUNTAS (6), SUPERIORMENTE, AO TUBO DE ACUMULAÇÃO (2), E INFERIORMENTE, AO TUBO DE RECOLHA (3), E UM SISTEMA DE ACUMULAÇÃO DO FLUIDO CIRCULANTE COM UM TUBO DE ACUMULAÇÃO (2), FIXADO NA EXTREMIDADE SUPERIOR DA PLACA ABSORSORA (1) ATRAVÉS DA JUNTA (6), CONTENDO UMA ABERTURA PARA COLOCAÇÃO DO TUBO DE ENCHIMENTO (7), UMA ABERTURA PARA A COLOCAÇÃO DO TUBO DE CIRCULAÇÃO (5), ISOLADO TERMICAMENTE, E DUAS ABERTURAS PARA ENTRADA E SAÍDA DOS TUBOS DO PERMUTADOR DE CALOR (4). A INVENÇÃO É APLICÁVEL A PAINÉIS FOTOVOLTAICOS PADRÃO JÁ INSTALADOS E PERTENCE AO DOMÍNIO TÉCNICO DOS COLECTORES SOLARES TÉRMICOS.
Patent RU-94004029-A (RU)
Inventor: VASIL EV M G
IPC: F27B1/00
Filed: 1993-02-04
Abstract: FIELD: non-ferrous metallurgy; devices for processing ore materials in molten-metal pool. SUBSTANCE: device has gas-lift reactor built in forehearth for liquid products of smelting; settler of gas-lift reactor is separated from pool of forehearth by means of partition in which slag-matte bellows is built. Partition forms through gas space between gas-lift reactor and gas duct. EFFECT: reduction of power requirements and capital outlays; improved ecological parameters and increased extraction of valuable components. 1 dwg
Patent RU-94013374-A (RU)
Inventor: SUVOROV I S
IPC: C06B33/00
Filed: 1994-04-15
Abstract: FIELD: devices intended for conversion of chemical energy of exothermic compounds to electric energy (primary single-action stand-by current sources); it is intended for short-time self-contained power supply of vehicle-borne equipment, instruments and devices at operation in holding pattern. SUBSTANCE: the device uses contacting anode and cathode made of pyrotechnic compounds and metal current taps at the following relation of components in electrodes, mass percent: anode-zirconium - 27 to 77; barium chromate - 10 to 45; lithium fluoride or fluorides of alkaline - earth metals or their mixture - 3 to 25; asbestos - 3 to 10; cathode - zirconium - 15 to 40; cupric oxide - 30 to 75; lithium fluoride or fluorides of alkali-earth metals or their mixture - 1 to 20; asbestos - 3 to 16, with the anode and cathode diameter - to-height ratio being equal to 30 to 80. At combustion of the anode and cathode charges (electrodes) chemical energy of the compounds is converter to electric energy with a high power and speed of response (low delay time between the instant of ignition and attaining of the maximum value of parameter). The device provides for creation of a battery of elementary cells at a proportional increase of EMF, voltage and other characteristics. The pyroelectric generator is small in size and self-contained in use, has a long guarantee period (5 to 10 years) at a storage and operating temperature within +-50 C, resistant to transport and operating overloads of all kinds. EFFECT: enhanced reliability.
Patent RU-94018632-A (RU)
Inventor: KUCHIN V D
IPC: C04B12/02
Filed: 1994-05-25
Abstract: FIELD: repair of lining of foundry ladle. SUBSTANCE: into mixture which comprises 42.5-59.8 mass % of finely dispersed waste of petrochemical industry and 25-50 mass % of phosphoric acid titanium dioxide and boron-containing compounds are additionally added. Quantities of titanium dioxide and said boron-containing compound (as calculated for boron dioxide) are 5-15 mass % and 0.2-2.5 mass % respectively. EFFECT: increased refractoriness and chemical resistance of mass.
Patent RU-94020395-A (RU)
Inventor: UVE ADLER
IPC: F02B61/00
Filed: 1992-10-06
Abstract: FIELD: automobile construction. SUBSTANCE: automobile with at least two independent electric generators driven by internal combustion engine. The generators supply with power at least one engine using at least one power electronic unit. As this takes place the electric motor is joint to at least one drive wheel of the automobile. The engine has at least two cylinders. The engine is subdivided into at least two independent sectional engines with own drive shaft each in terms of valve operation. Each shaft is connected to own generator. EFFECT: higher efficiency.
Patent RU-94021646-A (RU)
Inventor: FOL KKHART RUDERT
IPC: C04B28/04
Filed: 1994-06-22
Abstract: FIELD: medicine. SUBSTANCE: method involves the use of a single lignin-sulfonate that decreases the content of water-soluble Crin cement and/or cement-containing composition after water addition. Taken lignin-sulfonate is added to cement and/or cement-containing compositions before or during water addition in the process of the fresh cement-containing mixture preparing. Invention is related to the method of allergy SUPPRESSION. EFFECT: enhanced effectiveness of method.
Patent RU-94027055-A (RU)
Inventor: AFANAS EV A JU
IPC: E02B3/06
Filed: 1994-07-14
Abstract: FIELD: erection of wharfs and embankments on HARBOR water areas insufficiently protected against sea. SUBSTANCE: mooring structure has an undermoorage wave suppressing chamber in the form of a box formed by the front sheet piling with windows, superstructure slab, rear sheet piling with windows, superstructure slab, rear sheet piling and horizontal bedplate. The windows in the front sheet piling are formed by alternating sheet piles of different length, one of them have a length over the entire height of the structure and their ends are embedded in the superstructure, and the top of the others is positioned at the level of the bedplate of the wave suppressing chamber box. The rear sheet piling is rigidly embedded in the superstructure slab, and the bedplate of the wave suppressing chamber box is rigidly coupled to the front and rear sheet pilings. The wave suppressing chamber suppresses the wave approaching the structure and transfers its energy to the whole structure. Vertical load on the structure through the bedplate of the wave suppressing chamber box is transferred to the fill ground under it. Due to redistribution of load over a large area, the unit pressure on the foot of the bedplate of the wave suppressing chamber box and of the whole structure is reduced, which provides for erection of the structure of this design on soft ground of the bedplate. The front sheet piling may be coupled with an anchoring device in the rear part of the structure by an anchor rod, which enhances its stability. The cordon crane girder through the superstructure slab can rest on a vertical pile rigidly coupled to the bedplate of the wave suppressing chamber box, which provides for transfer of vertical load to more dense deep-seated layers and enhanced the structure bearing capacity. EFFECT: enhanced bearing capacity. 3 cl, 2 dwg
Patent RU-94037757-A (RU)
Inventor: GUZEEV V V
IPC: C08K3/22
Filed: 1994-10-07
Abstract: FIELD: polymer production. SUBSTANCE: stabilizer may be utilized when processing compositions of chlorine-containing polymers such as polyvinyl chloride, vinyl chloride copolymers, etc. into various articles (film materials, bottles, shaped objects, pipes, etc.). To improve total performance of materials resulted from processing of stabilized chlorine-containing polymers, stabilizer employed must include (in wt %): arylsulphonamidocapronic acid, 56-70; calcium oxide, 4.2-6.3; and zinc stearate, the balance; or arylsulphonamidocapronic acid, 28-55; lead oxide, 20-47; and calcium stearate, the balance. Stabilizer additionally contains 4- 8% maleic anhydride. Materials produced using this stabilizer, after aging, retain their initial color at the level of 0.82-0.96, have heat resistance 45-95 min, yellowness coefficient 13-24%, transparency coefficient 80-92%, extrusion output 130-170 g/min (for materials produced using 1st stabilizer version) and break strength 480-960 bending cycles (for materials produced using 2nd stabilizer version). EFFECT: improved performance of material.